Financial Result
| Rubicon Research Ltd Industry: (Pharmaceuticals - Indian - Formulations) |
|---|
|
BSE Code:
544578
ISIN Demat:
INE506V01022
Book Value(₹): 81.75 NSE Symbol:
RUBICON
Div & Yield(%):
0.09
Market Cap(₹ Cr): 28,415.60 P/E(TTM):
120.71
EPS(TTM):
14.22
Face Value(₹): 1.00 |
| Particulars | Mar '25 (₹ Cr) | Mar '24 (₹ Cr) | Mar '23 (₹ Cr) | Mar '22 (₹ Cr) | Mar '21 (₹ Cr) |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.34 | 0.72 | 0.96 | 0.68 | 0.31 |
| Long Term Debt-Equity Ratio | 0.11 | 0.16 | 0.27 | 0.22 | 0.12 |
| Current Ratio | 2.27 | 1.49 | 1.35 | 1.64 | 2.45 |
| Fixed Assets | 2.35 | 2.46 | 1.64 | 1.20 | 1.42 |
| Inventory | 4.31 | 4.89 | 3.62 | 3.50 | 7.01 |
| Debtors | 2.15 | 2.85 | 2.64 | 1.72 | 2.06 |
| Interest Cover Ratio | 9.16 | 7.51 | 2.12 | 0.42 | 2.88 |
| PBIDTM (%) | 24.61 | 26.97 | 15.79 | 11.17 | 14.36 |
| PBITM (%) | 21.72 | 23.99 | 10.25 | 2.01 | 6.48 |
| PBDTM (%) | 22.24 | 23.77 | 10.95 | 6.36 | 12.11 |
| CPM (%) | 17.30 | 18.58 | 9.41 | 4.87 | 12.05 |
| APATM (%) | 14.41 | 15.60 | 3.86 | -4.29 | 4.17 |
| ROCE (%) | 20.82 | 26.05 | 8.61 | 1.31 | 4.68 |
| RONW (%) | 18.62 | 29.30 | 6.39 | -4.72 | 3.97 |